(MENAFN- The Peninsula) A healthy British volunteer became the first person to receive a new vaccine for the Ebola virus in a trial at the University of Oxford yesterday.
The testing began as Britain announced it would increase aid to Sierra Leone to provide 700 treatment beds over the coming months, with military personnel helping their roll out.
US President Barack Obama this week urged action against the worst ever epidemic of the disease, warning it was "spiralling out of control".
The volunteer is one of 60 who will receive the drug at the University of Oxford in testing that will run alongside similar trials in the United States and could mean a vaccine being produced by the end of the year.
Researchers hope to establish whether the vaccine, which contains genetic material from the Ebola virus, can trigger the immune system to produce enough antibodies to fight off the disease, which has a mortality rate of over 50 percent.
The vaccine specifically targets the Zaire species of Ebola, which has killed 2,461 people out of 4,985 recorded cases in Guinea, Liberia, Senegal and Sierra Leone since the start of the year, according to World Health Organisation (WHO) data.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.